Valuation: DNA X, Inc.

Market Cap 4.63M 4.02M 3.73M 3.44M 6.49M 442M 6.6M 44.2M 17.31M 219M 17.38M 17M 738M P/E 2024
-0.44x
P/E 2025 -0.11x
Enterprise Value 8.39M 7.29M 6.77M 6.24M 11.76M 801M 11.97M 80.12M 31.37M 398M 31.51M 30.82M 1.34B EV / Sales 2024
0.17x
EV / Sales 2025 -
Free-Float
63.9%
Yield 2024 *
-
Yield 2025 -
1 day+2.89%
1 week+2.24%
Current month-37.86%
1 month-37.86%
3 months-37.86%
6 months-43.26%
Current year+1.59%
1 week 3
Extreme 3
3.29
1 month 2.8
Extreme 2.8
5.3
Current year 2.62
Extreme 2.62
7.97
1 year 2.52
Extreme 2.5211
16.97
3 years 2.52
Extreme 2.5211
192.6
5 years 2.52
Extreme 2.5211
1,322.28
10 years 2.52
Extreme 2.5211
32,863.47
Manager TitleAgeSince
Chief Executive Officer 63 2026-02-08
Director of Finance/CFO 64 2022-07-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 63 2023-11-12
Director/Board Member 64 2022-07-12
Director/Board Member 79 2022-07-12
Date Insider Type Main position Quantity % Market Cap.
2/9/26 Free

Chief Executive Officer

50,000 3.3592%
2/9/26 Free

Chief Financial Officer

35,000 2.3514%
7/18/25 Other

Director

723 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
+2.89%+2.24%-74.54%-98.22% 4.63M
-0.72%-20.54%+193.20%+193.20% 915B
+4.51%+10.91%-19.29%+27.86% 1.74B
-2.77%+10.56%+30.58%+325.82% 1.34B
-1.82%-9.56%-7.68%-32.41% 995M
-2.27%-16.12%+43.02%+11.02% 883M
-0.88%+0.63%+4.59%+197.24% 579M
-5.00%-20.50%-33.39%+14.50% 465M
-4.18%+3.97%+9.88%-12.20% 424M
+0.28%-1.09%-25.92%+286.99% 179M
Average -1.00%-3.98%+12.05%+91.38% 92.14B
Weighted average by Cap. -0.72%-16.90%+191.84%+192.50%

Financials

2024 2025
Net sales 58.3M 50.64M 47.02M 43.37M 81.69M 5.57B 83.17M 557M 218M 2.76B 219M 214M 9.3B -
Net income -33.65M -29.23M -27.14M -25.03M -47.15M -3.21B -48M -321M -126M -1.6B -126M -124M -5.37B -20.66M -17.94M -16.66M -15.37M -28.95M -1.97B -29.47M -197M -77.23M -979M -77.57M -75.88M -3.29B
Net Debt -5.34M -4.64M -4.31M -3.97M -7.49M -510M -7.62M -51.02M -19.98M -253M -20.06M -19.63M -852M 3.76M 3.27M 3.03M 2.8M 5.27M 359M 5.37M 35.92M 14.07M 178M 14.13M 13.82M 600M
Logo DNA X, Inc.
DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong.
Employees
4
Date Price Change Volume
26-07-30 US$3.200 +2.89% 1,293
26-07-29 US$3.110 +2.64% 17,546
26-07-28 US$3.030 -5.02% 2,340
26-07-27 US$3.190 +1.24% 4,298
26-07-24 US$3.151 +0.66% 3,999

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SONM Stock